Literature DB >> 21240472

Food for thought ... considerations and guidelines for basic test method descriptions in toxicology.

Marcel Leist1, Liudmila Efremova, Christiaan Karreman.   

Abstract

The development and application of new test systems and test methods is central to the progress of in vitro toxicology. In order to live up to the future challenges, it is important to use the vast knowledge of adjoining fields, such as cell biology or developmental biology, and to attract specialists from such areas to develop new methods. Not all of them bring with them the necessary experience and training required for the development of toxicological test systems. Thus, promising new biological test systems sometimes still require additional considerations to become successful. Sometimes even the referees of scientific journals and their editors seem to lack judgement guidelines for minimum performance standards. Here we provide a list of points to be considered for the establishment of a test method. The chapters range from the explanation of the meaning of positive controls, performance standards or signal-noise ratios to a discussion of statistical considerations, suitable solvents and data display formats. The considerations are simple and expressed in a non-mathematical format, with a strong focus on plausibility and common sense. The major intention of this article is to provide a compilation of important issues requiring consideration. Whether they apply to a specific system and whether action is required must be determined by individual judgement.

Mesh:

Year:  2010        PMID: 21240472     DOI: 10.14573/altex.2010.4.309

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  23 in total

Review 1.  Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

Authors:  Lena Smirnova; Helena T Hogberg; Marcel Leist; Thomas Hartung
Journal:  ALTEX       Date:  2014       Impact factor: 6.043

Review 2.  Translating neurobehavioural endpoints of developmental neurotoxicity tests into in vitro assays and readouts.

Authors:  Christoph van Thriel; Remco H S Westerink; Christian Beste; Ambuja S Bale; Pamela J Lein; Marcel Leist
Journal:  Neurotoxicology       Date:  2011-10-12       Impact factor: 4.294

3.  21st Century Cell Culture for 21st Century Toxicology.

Authors:  David Pamies; Thomas Hartung
Journal:  Chem Res Toxicol       Date:  2016-12-05       Impact factor: 3.739

4.  Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation.

Authors:  Vaibhav Shinde; Stefanie Klima; Perumal Srinivasan Sureshkumar; Kesavan Meganathan; Smita Jagtap; Eugen Rempel; Jörg Rahnenführer; Jan Georg Hengstler; Tanja Waldmann; Jürgen Hescheler; Marcel Leist; Agapios Sachinidis
Journal:  J Vis Exp       Date:  2015-06-17       Impact factor: 1.355

5.  Perspectives on validation of high-throughput assays supporting 21st century toxicity testing.

Authors:  Richard Judson; Robert Kavlock; Matthew Martin; David Reif; Keith Houck; Thomas Knudsen; Ann Richard; Raymond R Tice; Maurice Whelan; Menghang Xia; Ruili Huang; Christopher Austin; George Daston; Thomas Hartung; John R Fowle; William Wooge; Weida Tong; David Dix
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

6.  Look back in anger - what clinical studies tell us about preclinical work.

Authors:  Thomas Hartung
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

7.  Metabolomics in toxicology and preclinical research.

Authors:  Tzutzuy Ramirez; Mardas Daneshian; Hennicke Kamp; Frederic Y Bois; Malcolm R Clench; Muireann Coen; Beth Donley; Steven M Fischer; Drew R Ekman; Eric Fabian; Claude Guillou; Joachim Heuer; Helena T Hogberg; Harald Jungnickel; Hector C Keun; Gerhard Krennrich; Eckart Krupp; Andreas Luch; Fozia Noor; Erik Peter; Bjoern Riefke; Mark Seymour; Nigel Skinner; Lena Smirnova; Elwin Verheij; Silvia Wagner; Thomas Hartung; Bennard van Ravenzwaay; Marcel Leist
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

8.  Mechanistic validation.

Authors:  Thomas Hartung; Sebastian Hoffmann; Martin Stephens
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

9.  Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.

Authors:  Anne K Krug; Raivo Kolde; John A Gaspar; Eugen Rempel; Nina V Balmer; Kesavan Meganathan; Kinga Vojnits; Mathurin Baquié; Tanja Waldmann; Roberto Ensenat-Waser; Smita Jagtap; Richard M Evans; Stephanie Julien; Hedi Peterson; Dimitra Zagoura; Suzanne Kadereit; Daniel Gerhard; Isaia Sotiriadou; Michael Heke; Karthick Natarajan; Margit Henry; Johannes Winkler; Rosemarie Marchan; Luc Stoppini; Sieto Bosgra; Joost Westerhout; Miriam Verwei; Jaak Vilo; Andreas Kortenkamp; Jürgen Hescheler; Ludwig Hothorn; Susanne Bremer; Christoph van Thriel; Karl-Heinz Krause; Jan G Hengstler; Jörg Rahnenführer; Marcel Leist; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2012-11-21       Impact factor: 5.153

Review 10.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.